Holistic Health Blog
Dr. Cathy Rosenbaum

Medication Overprescribing – Time to Start Thinking Out of the Box (Pill Vial)

Many seniors are taking five medications a day.  Some are taking many more than that.  Are USA physicians overprescribing?  Is there a way we can encourage them to start thinking out of the box and consider other evidence-based non-invasive modalities first, whenever possible?

Here’s a list of medications that may be problematic for seniors (American Geriatrics Society 2019 Beers Criteria). Take this article to your primary care physician for discussion of med risk/benefit if you are taking any of them.

https://nicheprogram.org/sites/niche/files/2019-02/Panel-2019-Journal_of_the_American_Geriatrics_Society.pdf

Holistic Health and Wellness Trends for 2019

Wondering where holistic health and wellness is going in America in 2019?  Here’s a short list of categories that will be popping up in the press and in the marketplace.  Oh, the places we will go!

Which of these is your favorite wellness topic and why?

  • Plant-based fish (in addition to plant-based meat)
  • Circadian rhythm’s impact on restful sleep
  • Brain health
  • Post-surgical recovery gadgets (foam rolling, TheraGun, more)
  • Ayurveda and the mind-body connection
  • Wine as a farm-to-table commodity
  • The microbiome (gut/immune health)
  • Telemedicine
  • The  endocannabinoid system
  • Wearable healthcare gadgets

For more information on upcoming events, health coaching packages, or to schedule a seminar/workshop on holistic health and wellness for your corporate or small group, please email Dr. Cathy Rosenbaum @ drcathy@rxintegrativesolutions.com or visit www.Facebook.com/rxintegrativesolutions.

Pharmacogenomics Testing and Precision Medicine

In 2018, 23andMe received FDA approval to market a pharmacogenomic test that examines eight different human genes. This test will be obtained without a doctor’s order and will give the consumer information on how he/she metabolizes 50 prescription and OTC medications. FDA is saying, “buyer beware.”

Should pharmacogenomic tests be available to consumers without a physician’s order or healthcare professional’s involvement in test interpretation?